Psychedelics Co. Silo Wellness To Acquire Dyscovry Science, Seeking To Leverage Its Govt. Partnerships
Exclusive details on Silo Wellness' proposed acquisition of Dyscovry Science, a company that, unlike most of its peers in the psychedelics space, which focus on mental health issues, is targeting a physiological condition: irritable bowel syndrome.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Javier Hasse, Senior Contributor Tags: Vices /vices Lifestyle /lifestyle Innovation /innovation Healthcare /healthcare javierhasseblog Source Type: news
More News: Irritable Bowel Syndrome | Men | Mergers and Aquisitions | Partnerships | Pharmaceuticals | Science